Results of two phase 2 studies suggest efgartigimod could be a potential treatment for myositis and Sjögren disease in ...

Dr Amal Mattu breaks down the key updates — and lingering pitfalls — in the 2025 ACS guidelines that every acute care ...

Emapalumab is approved for both adults and pediatric (newborn and older) patients with MAS in Still disease with an inadequate response or intolerance to glucocorticoids, or with recurrent MAS.

Specifically, the FDA removed the Risk Evaluation and Mitigation Strategy (REMS) program requirements from two BCMA-directed CAR T-cell therapies for multiple myeloma — ciltacabtagene autoleucel ...

Lorundrostat, an aldosterone synthase inhibitor, effectively treated uncontrolled hypertension in Launch-HTN, researchers ...

Vaccine hesitancy is understandable given the number and nature of early-childhood immunizations. Clinicians should proactively identify when vaccines are due, understand true vs false ...

A novel predictive model named STAYHOME effectively estimated the risk of losing the ability to live at home among older ...

Despite the absence of pain signals, post-operative opioids control tachycardia and hypertension, highlighting the unique challenges in pain-insensitive individuals.

Brad Spellberg, MD, urges rethinking the ‘finish the course’ dogma for antibiotics: Extra days may do more harm than good.

Forensics specialist Emmanuel Margueritte, MD, explains when physicians must flag a death for judicial review under France’s new medico-legal guidelines.

New data suggest mid/distal esophageal coin retention in kids often resolves without intervention — prompting reconsideration ...

A tight control treatment with golimumab in early, active axial spondyloarthritis induces high rates of sustained clinical ...